TMO
42
-6
PG
50
2
STX
45
-4
KEY
43
-3
TDC
67
-4
PSA
56
3
FITB
60
-5
MTB
65
-2
EBAY
42
-2
SWK
50
-5
T
48
3
V
64
-2
IBM
47
-3
GIS
22
-4
CNX
73
-3
LEN
50
-2
TRIP
50
-4
PVH
60
-4
WMB
68
2
CI
45
-3
TMO
42
-6
PG
50
2
STX
45
-4
KEY
43
-3
TDC
67
-4
PSA
56
3
FITB
60
-5
MTB
65
-2
EBAY
42
-2
SWK
50
-5
T
48
3
V
64
-2
IBM
47
-3
GIS
22
-4
CNX
73
-3
LEN
50
-2
TRIP
50
-4
PVH
60
-4
WMB
68
2
CI
45
-3
Financhill
Back

SPDR® Portfolio Short Term Corp Bd ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
33

SPSB
SPDR® Portfolio Short Term Corp Bd ETF

Last Price:
29.92
Seasonality Move:
0.08%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
33
SPDR® Portfolio Short Term Corp Bd ETF (SPSB) is a Sell

Is SPDR® Portfolio Short Term Corp Bd ETF a Buy, Sell or Hold?

  • The current SPDR® Portfolio Short Term Corp Bd ETF [SPSB] share price is $29.91. The Score for SPSB is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • SPSB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPSB Stock Price Chart

What is SPDR® Portfolio Short Term Corp Bd ETF's stock price today?

  • The SPDR® Portfolio Short Term Corp Bd ETF share price today is $29.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPSB is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SPSB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 39.44 Sell
Chaikin Money Flow: 203103 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.92 - 30.06) Sell
Bollinger Bands (100): (29.83 - 30.17) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SPSB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.92 Sell
20-day SMA: 29.97 Sell
50-day SMA: 30.09 Sell
200-day SMA: 29.83 Buy
8-day EMA: 29.92 Sell
20-day EMA: 29.97 Sell
50-day EMA: 30.02 Sell
200-day EMA: 29.87 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

SPDR® Portfolio Short Term Corp Bd ETF Earnings Growth & SPSB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

SPDR® Portfolio Short Term Corp Bd ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):